Have a personal or library account? Click to login
Novel Oral Anticoagulants in Renal Transplant Recipients: A Retrospective Cohort Study Cover

Novel Oral Anticoagulants in Renal Transplant Recipients: A Retrospective Cohort Study

PRILOZI
Volume 41 (2020): Issue 2 (September 2020)
By: Nikolina Basic-Jukic,  Vesna Furic-Cunko and  Ivana Juric  
Open Access
|Oct 2020

Authors

Nikolina Basic-Jukic

nina_basic@net.hr

Department of nephrology, arterial hypertension, dialysis and transplantation, University hospital centre Zagreb, Faculty of medicine, University of Zagreb, Zagreb

Vesna Furic-Cunko

Department of nephrology, arterial hypertension, dialysis and transplantation, University hospital centre Zagreb, Faculty of medicine, University of Zagreb, Zagreb

Ivana Juric

Department of nephrology, arterial hypertension, dialysis and transplantation, University hospital centre Zagreb, Faculty of medicine, University of Zagreb, Zagreb
DOI: https://doi.org/10.2478/prilozi-2020-0032 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 49 - 55
Published on: Oct 2, 2020
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
novel anticoagulant drugs,
rivaroxaban,
apixaban,
dabigatran,
renal transplantation
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2020 Nikolina Basic-Jukic, Vesna Furic-Cunko, Ivana Juric, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 41 (2020): Issue 2 (September 2020)Next article